Literature DB >> 18558643

Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients.

Joseph I Friedman1, Cheuk Tang, David Carpenter, Monte Buchsbaum, James Schmeidler, Lauren Flanagan, Shana Golembo, Isabella Kanellopoulou, Johnny Ng, Patrick R Hof, Philip D Harvey, Nicholas D Tsopelas, Daniel Stewart, Kenneth L Davis.   

Abstract

OBJECTIVE: Comparisons of diffusion tensor imaging (DTI) data between first-episode and chronic schizophrenia patients assessed in different studies have led to the suggestion that the decreased fractional anisotropy observed in chronic schizophrenia patients is less pronounced in first-episode patients. However, such comparisons of imaging data generated across studies are susceptible to numerous confounders, which may limit the interpretation of any differences. In order to address these issues and determine whether the DTI abnormalities of chronic schizophrenia are present at illness onset, the authors conducted a DTI investigation of the largest cohort of first-episode schizophrenia patients yet reported in conjunction with a group of chronic schizophrenia patients and healthy subjects for comparison.
METHOD: Fractional anisotropy data generated by diffusion tensor imaging with a 3-T Siemens Allegra head-dedicated MRI system were compared between 40 first-episode schizophrenia patients and 39 age- and gender-matched healthy comparison subjects and between 40 chronic schizophrenia patients and 40 age- and gender-matched healthy comparison subjects. The following regions of interest were assessed: forceps minor (bilaterally), forceps major (bilaterally), inferior longitudinal fasciculus (bilaterally), and the genu and splenium of the corpus callosum.
RESULTS: In most regions, chronic schizophrenia patients showed significant or trend-level lower fractional anisotropy than healthy comparison subjects, whereas the first-episode schizophrenia patients showed only trend-level lower fractional anisotropy in the inferior longitudinal fasciculus.
CONCLUSIONS: The cross-sectional data reported here suggest less widespread changes in white matter at illness onset in schizophrenia which progress in more chronic states. More definitive conclusions will require follow-up imaging of first-episode schizophrenia patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18558643     DOI: 10.1176/appi.ajp.2008.07101640

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  104 in total

Review 1.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

2.  Oligodendrocyte genes, white matter tract integrity, and cognition in schizophrenia.

Authors:  Aristotle N Voineskos; Daniel Felsky; Natasa Kovacevic; Arun K Tiwari; Clement Zai; M Mallar Chakravarty; Nancy J Lobaugh; Martha E Shenton; Tarek K Rajji; Dielle Miranda; Bruce G Pollock; Benoit H Mulsant; Anthony R McIntosh; James L Kennedy
Journal:  Cereb Cortex       Date:  2012-07-06       Impact factor: 5.357

Review 3.  Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.

Authors:  George Bartzokis
Journal:  Neuropharmacology       Date:  2012-01-28       Impact factor: 5.250

4.  Accelerated white matter aging in schizophrenia: role of white matter blood perfusion.

Authors:  Susan Wright; Peter Kochunov; Joshua Chiappelli; Robert McMahon; Florian Muellerklein; S Andrea Wijtenburg; Michael G White; Laura M Rowland; L Elliot Hong
Journal:  Neurobiol Aging       Date:  2014-02-28       Impact factor: 4.673

5.  Biomarkers for identifying first-episode schizophrenia patients using diffusion weighted imaging.

Authors:  Yogesh Rathi; James Malcolm; Oleg Michailovich; Jill Goldstein; Larry Seidman; Robert W McCarley; Carl-Fredrik Westin; Martha E Shenton
Journal:  Med Image Comput Comput Assist Interv       Date:  2010

6.  White matter integrity and prediction of social and role functioning in subjects at ultra-high risk for psychosis.

Authors:  Katherine H Karlsgodt; Tara A Niendam; Carrie E Bearden; Tyrone D Cannon
Journal:  Biol Psychiatry       Date:  2009-05-07       Impact factor: 13.382

7.  Dysregulated Maturation of the Functional Connectome in Antipsychotic-Naïve, First-Episode Patients With Adolescent-Onset Schizophrenia.

Authors:  Meiling Li; Benjamin Becker; Junjie Zheng; Yan Zhang; Heng Chen; Wei Liao; Xujun Duan; Hesheng Liu; Jingping Zhao; Huafu Chen
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306

8.  Integration of routine QA data into mega-analysis may improve quality and sensitivity of multisite diffusion tensor imaging studies.

Authors:  Peter Kochunov; Erin W Dickie; Joseph D Viviano; Jessica Turner; Peter B Kingsley; Neda Jahanshad; Paul M Thompson; Meghann C Ryan; Els Fieremans; Dmitry Novikov; Jelle Veraart; Elliot L Hong; Anil K Malhotra; Robert W Buchanan; Sofia Chavez; Aristotle N Voineskos
Journal:  Hum Brain Mapp       Date:  2017-11-27       Impact factor: 5.038

9.  Processing speed impairment in schizophrenia is mediated by white matter integrity.

Authors:  H Karbasforoushan; B Duffy; J U Blackford; N D Woodward
Journal:  Psychol Med       Date:  2014-05-15       Impact factor: 7.723

10.  Global white matter abnormalities in schizophrenia: a multisite diffusion tensor imaging study.

Authors:  Tonya White; Vincent A Magnotta; H Jeremy Bockholt; Sumner Williams; Stuart Wallace; Stefan Ehrlich; Bryon A Mueller; Beng-Choon Ho; Rex E Jung; Vincent P Clark; John Lauriello; Juan R Bustillo; S Charles Schulz; Randy L Gollub; Nancy C Andreasen; Vince D Calhoun; Kelvin O Lim
Journal:  Schizophr Bull       Date:  2009-09-21       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.